Aptose Biosciences Inc (APTO)
1.18
-0.01
(-0.84%)
USD |
NASDAQ |
May 17, 16:00
1.15
-0.03
(-2.54%)
After-Hours: 20:00
Aptose Biosciences Total Assets (Quarterly): 12.80M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.80M |
| December 31, 2023 | 12.99M |
| September 30, 2023 | 20.88M |
| June 30, 2023 | 26.58M |
| March 31, 2023 | 39.33M |
| December 31, 2022 | 51.03M |
| September 30, 2022 | 57.05M |
| June 30, 2022 | 64.80M |
| March 31, 2022 | 72.60M |
| December 31, 2021 | 82.52M |
| September 30, 2021 | 97.20M |
| June 30, 2021 | 106.21M |
| March 31, 2021 | 115.20M |
| December 31, 2020 | 126.26M |
| September 30, 2020 | 135.26M |
| June 30, 2020 | 85.32M |
| March 31, 2020 | 92.56M |
| December 31, 2019 | 100.48M |
| September 30, 2019 | 32.46M |
| June 30, 2019 | 38.19M |
| March 31, 2019 | 19.72M |
| December 31, 2018 | 16.87M |
| September 30, 2018 | 16.30M |
| June 30, 2018 | 19.29M |
| March 31, 2018 | 16.67M |
| Date | Value |
|---|---|
| December 31, 2017 | 11.97M |
| September 30, 2017 | 11.21M |
| June 30, 2017 | 11.29M |
| March 31, 2017 | 9.505M |
| December 31, 2016 | 8.646M |
| September 30, 2016 | 8.449M |
| June 30, 2016 | 10.46M |
| March 31, 2016 | 12.49M |
| December 31, 2015 | 15.35M |
| September 30, 2015 | 18.13M |
| June 30, 2015 | 21.30M |
| March 31, 2015 | 23.77M |
| September 30, 2014 | 30.27M |
| May 31, 2014 | 28.48M |
| February 28, 2014 | 6.960M |
| November 30, 2013 | 2.115M |
| August 31, 2013 | 0.9306M |
| May 31, 2013 | 1.004M |
| February 28, 2013 | 1.792M |
| November 30, 2012 | 3.238M |
| August 31, 2012 | 4.637M |
| May 31, 2012 | 0.6482M |
| February 29, 2012 | 0.5089M |
| November 30, 2011 | 1.345M |
| August 31, 2011 | 2.324M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.80M
Minimum
Mar 2024
135.26M
Maximum
Sep 2020
68.48M
Average
68.70M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.66M |
| Shareholders Equity (Quarterly) | 0.137M |